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Inducible cAMP Early Repressor Regulates Corticosterone
Suppression after Tricyclic Antidepressant Treatment
Alana C. Conti,1 Yuo-Chen Kuo,1 Rita J. Valentino,3 and Julie A. Blendy1,2
1Department of Pharmacology and 2Center for Neurobiology and Behavior, University of Pennsylvania, and 3The Children’s Hospital of Philadelphia,
Abramson Pediatric Research Center, Philadelphia, Pennsylvania 19104
The cAMP-response element binding protein (CREB) is involved in antidepressant action, but the role of related CRE-binding transcrip-
tion factors in the behavioral and endocrine responses to antidepressants is unclear. Alternative transcription of the cAMP response
element-modulator (CREM) gene yields activator and repressor isoforms, including the strong repressor inducible cAMP early repressor
(ICER). ICER is highly expressed in hypothalamic tissues and upregulated after electroconvulsive seizure. Thus, ICER may be a novel
mediator of antidepressant action at endocrine and/or behavioral levels. Here we establish that both subchronic and chronic desipramine
(DMI) treatments upregulate hypothalamic ICER expression in wild-type mice. Behavioral responses to DMI in the forced swim and tail
suspension tests are unchanged in mice lacking ICER. However, the ability of DMI to suppress an acute corticosterone response after
swim stress is compromised in ICER-deficient mice, suggesting that increased hypothalamic ICER mRNA after DMI treatment may be
required for suppression of corticosterone release. To investigate the mechanism underlying this response, we measured corticotropin
releasing factor (CRF), an upstream modulator of corticosterone release. Using real-time quantitative PCR, we establish that hypotha-
lamic CRF expression is significantly reduced after swim exposure in DMI-treated wild-type mice, however DMI is unable to blunt
hypothalamic CRF expression in ICER-deficient mice. Furthermore, we demonstrate that ICER is enriched in CRF-expressing neurons in
the paraventricular nucleus of the hypothalamus. These data indicate that ICER is required for DMI to reduce stress-induced corticoste-
rone release through regulation of hypothalamic CRF expression, revealing a novel role for ICER in antidepressant regulation of the
hypothalamic–pituitary adrenal axis.
Key words: ICER; CREM; corticotropin releasing factor; stress; antidepressant; desipramine; corticosterone; real-time quantitative PCR;
CRH; forced swim test; tail suspension test
Introduction
Antidepressant drugs are widely prescribed and often effective in
treating clinical depression; however, the mechanisms of action
that underlie long-term therapeutic benefits remain poorly un-
derstood. The focus of research has shifted from acute drug ac-
tion on neurotransmitter transporters to long-term cellular
changes that regulate gene expression. Long-term adaptations,
including alterations in intracellular signal transduction cas-
cades, are believed to be critical for the efficacy of chronic anti-
depressant treatment. Identification of such intracellular signal-
ing cascades and downstream gene targets is necessary to
understand the complexities associated with clinical depression
and will facilitate the development of more effective therapies.
Alterations in the cAMP signaling pathway have been impli-
cated in the mechanism of chronic antidepressant treatment
(Nibuya et al., 1996; Dowlatshahi et al., 1998, 1999; Thome et al.,
2000; Conti et al., 2002). The cAMP signaling pathway exerts its
transcriptional effects through a family of transcription factors
(TFs) that bind to cAMP- responsive elements (CREs), including
CRE-binding protein (CREB), CRE modulator (CREM), and Ac-
tivating TF-1 (ATF-1) (Gonzalez and Montminy, 1989; Lee and
Masson, 1993; Molina et al., 1993; Lalli and Sassone-Corsi, 1994).
CREB remains the most widely studied member of the CRE-
binding transcription factor family and has been implicated in
the mechanisms underlying antidepressant drug efficacy (Nibuya
et al., 1996; Dowlatshahi et al., 1998; Conti et al., 2002). However,
the role of related CRE-binding transcription factors in antide-
pressant action has not been evaluated.
The CREM gene is multiexonic and produces several tissue-
specific protein variants known to activate as well as inhibit
cAMP-responsive gene expression. The primary CREM activator
isoform, CREM , is highly expressed in the testes with little
expression in brain (Foulkes et al., 1992). Transcription at an
alternative promoter site yields a powerful tissue-specific repres-
sor isoform of CREM, the inducible cAMP early repressor
(ICER). Unlike CREB and CREM , ICER does not contain a
kinase-inducible domain and therefore is regulated by changes in
its expression level, not by phosphorylation. ICER is classified as
a unique early response transcription factor because of its dy-
namic, and direct cAMP inducibility, which is believed to be
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regulated via four tandem CRE sequences in the ICER promoter
(Molina et al., 1993). ICER is the most highly expressed CREM
isoform in neuroendocrine tissues (Mellstrom et al., 1993; Mo-
lina et al., 1993; Stehle et al., 1993), with cell-specific expression in
magnocellular neurons of the hypothalamus (Mellstrom et al.,
1993; Luckman and Cox, 1995). Furthermore, ICER expression is
significantly upregulated in the pituitary and adrenal glands after
hypothalamic–pituitary–adrenal (HPA) axis stimulation (Della
Fazia et al., 1998; Mazzucchelli and Sassone-Corsi, 1999). In ad-
dition to endocrine regulation of ICER, adrenergic stimulation
and electroconvulsive seizures increase ICER expression in brain
regions associated with antidepressant efficacy, suggesting a role
for ICER in the actions of antidepressant therapies (Fitzgerald et
al., 1996a,b).
In this study, we examined the effect of subchronic and
chronic DMI administration on ICER mRNA in the hypothala-
mus of wild-type mice. Using ICER-deficient mice, we investi-
gated whether the observed upregulation of ICER is of functional
consequence for either the behavioral or endocrine response to
chronic antidepressant treatment. We show that the behavioral
responses to antidepressants, as well as stress-induced elevations
in corticosterone levels, are independent of ICER expression.
However, the ability of antidepressant drugs to block corticoste-
rone release in response to stress is severely impaired in the ab-
sence of ICER. Our study demonstrates that ICER is enriched in
cells of the paraventricular nucleus and is essential for the ability
of antidepressants to regulate the stress-induced activation of the
hypothalamic–pituitary–adrenal axis. Together, these studies es-
tablish for the first time a role for antidepressant-induced ICER
in the regulation of this neuroendocrine system.
Materials and Methods
Animals. The derivation of mice lacking the CREM gene, including the
ICER isoform, has been described previously (Blendy et al., 1996). All
isoforms of the CREM gene are deleted in CREM mutant mice. This null
allele is maintained in two separate inbred mouse strains, 129SvEv and
C57BL/6, and has been backcrossed for several generations (N11 and
N14, respectively) to establish congenic strains. For all experiments de-
scribed here, CREM mutants and wild-type controls are F1 hybrids ob-
tained from crossing mice heterozygous for the null allele from each
parental inbred strain (129SvEv and C57BL/6). Thus, in the F1 genera-
tion, all mice are heterozygous for all loci that differ between the parental
strains and are genetically identical with the exception of the CREM
locus. This breeding scheme allows for rigorous control of the genetic
background of experimental animals over time and is in agreement with
the recommendations of the Branbury Conference on Genetic Back-
ground in Mice (Silva et al., 1997). All mice (3–5 months old, 23– 40 gm)
were group-housed and maintained on a 12 hr light/dark cycle with food
and water available ad libitum in accordance with the University of Penn-
sylvania Animal Care and Use Committee. All experimental testing ses-
sions were conducted between 12:00 P.M. and 6:00 P.M., with animals
randomly assigned to treatment conditions and tested in counterbal-
anced order.
Drugs. Desipramine (DMI; Sigma, St. Louis, MO) was freshly prepared
before use and injected intraperitoneally using a volume of 10 ml/kg. All
drug doses were calculated as milligram per kilogram base weight and
were dissolved in 0.9% saline.
Forced swim test. To facilitate adaptation to novel surroundings, mice
were transported to the testing room at least 1 hr before testing. Briefly,
swim sessions were conducted by placing mice in individual glass cylin-
ders (46 cm tall 20.5 cm diameter) containing 23–25°C water at a depth
of 10 cm. Whereas the procedure was similar to that described by Porsolt
et al. (1977) for rats, a cylinder of larger diameter was used because a
larger tank diameter increases predictive validity in the mouse forced
swim test (FST) (Sunal et al., 1994). Subjects were given a 15 min pre-
swim, occurring 23.5 hr before the first test swim. On test days a 6 min
test duration was used, and the water was changed between subjects. All
test sessions were recorded by a video camera positioned directly above
the cylinders. Videotapes were scored by a trained observer who was
blinded to the experimental conditions. The behavioral measure scored
was the duration of “immobility”, defined as the state in which mice were
judged to be making only the movements necessary to keep their head
above water.
Saline or DMI was administered subchronically by giving three injec-
tions over a 24 hr period (n 6 –12 per group). Doses were given at 23.5,
5.0, and 1.0 hr (10, 10, and 20 mg/kg, s.c., respectively) before the first test
swim. Data obtained from pilot experiments showed robust behavioral
changes after this dosing strategy. For chronic experiments animals were
maintained on saline or DMI injections twice daily (10 mg/kg, i.p.) for
21 d. On day 21, morning injections were administered 5 hr before FST,
and afternoon injections (saline or 20 mg/kg DMI, s.c.) were adminis-
tered 1 hr before FST. This dosing regimen was used to allow for com-
parison of behavioral data obtained from subchronic and chronic
studies.
Tail suspension test. Animals were tested in a modified version of the
tail suspension test (TST) that has been previously validated (Steru et al.,
1985). All mice were adapted to novel surroundings and tested as de-
scribed for the FST. Subjects were each given saline, DMI, or fluoxetine
(FLX; 20 mg/kg, i.p.; n 8 –10 per group). Thirty minutes after injection,
mice were individually suspended by the tail to a horizontal ring-stand
bar (distance from floor  35 cm) using Fisherbrand (Fisher Scientific,
Pittsburgh, PA) adhesive tape affixed 2 cm from the tip of the tail. The
dosing paradigm was selected from previous studies showing robust be-
havioral changes under these conditions (Lucki, 2001; Lucki et al., 2001).
Mice demonstrated several escape-oriented behaviors interspersed with
bouts of immobility as the session progressed. A 6 min test session was
used that was recorded by a video camera positioned in front of the tail
suspension apparatus. Videotapes were scored by a trained observer who
was blinded to the experimental conditions. The behavioral measure
scored was the duration of “immobility”, defined as the time when mice
were judged to cease escape-motivated behaviors.
RNA isolation and cDNA synthesis. After cervical dislocation, brains
were dissected for RNA analysis (n  6 –12 per group). All RNA was
isolated using TRIzol (Invitrogen, Gaithersburg, MD) according to man-
ufacturer’s instructions. The quality of the RNA samples was determined
by ethidium bromide staining of 18 S and 28 S rRNAs after fractionation
on denaturing agarose gels. Contaminating genomic DNA was removed
using 1 l of RNase-free DNase I (Boehringer Mannheim, Indianapolis,
IN)/10 g of RNA at 37°C for 30 min. cDNA was synthesized using
Moloney murine leukemia virus-reverse transcriptase (Invitrogen) with
deoxyribonucleotides (dNTPs) and random hexamer primers RT (In-
vitrogen) at 42°C for 30 min.
A subset of animals was used to measure the time course of ICER
expression after DMI treatment. Animals were killed at 1 hr after the last
DMI or saline injection (n  6 –7 per group) to determine effects of
subchronic DMI treatment. Animals were killed following 21 d of saline
or DMI administration to determine effects of chronic treatment. To
measure corticotropin-releasing factor (CRF) expression after swim ex-
posure, animals were killed 1 hr after FST testing on day 21 of chronic
treatment.
RT-PCR. Conditions used for RT-PCR followed the method of Wilson
and Melton (1994) with minimal modifications. The mouse hypoxan-
thine guanine phosphoribosyl transferase (HPRT) gene was used as an
internal control, because the mRNA of this gene is expressed in most
tissues in approximately equal amounts. cDNAs synthesized from hypo-
thalamic, hippocampal, and cortical RNA provided templates for PCRs
under the following conditions: one cycle of 95°C for 5 min, followed by
25 cycles of 95°C for 1 min, 60°C for 1 min, 72°C for 2 min, and one cycle
of 72°C for 5 min in a buffer containing 1.5 mmol/l MgCl2, 10 mol/l
primers, 0.05 Ci 32P-dATP, and 200 mol/l dNTPs. The forward and
reverse primers used were as follows: Icer-1 (222 bp) and Icer -1 (258
bp): 5-CCCAACATGGCTGTAACTGGA (forward) and 5-GCACAG-
CCACACGATTTTCAA (reverse); Hprt (111 bp): 5-GGCCATCTGCC-
TAGTAAAGCT (forward) and 5-GCTGGCCTATAGGCTCATAGT-
(reverse).
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PCR products were separated on 5% acrylamide gels that were dried
and exposed to PhosphorImager screens overnight. Combined signal
intensity of ICER amplification products (ICER-1 ICER-1) was nor-
malized to that of HPRT. Under the conditions used, determination of
mRNA levels by RT-PCR was quantitative, as PhosphorImager analysis
(ImageQuant; Molecular Dynamics, Sunnyvale, CA) of amplified prod-
ucts from serially diluted cDNAs confirmed the linearity of the assay for
all primers used (data not shown).
Real-time quantitative PCR. Primers and fluorescent probes were de-
signed using the Primer Express 1.5 software (Applied Biosystems, Foster
City, CA) and purchased from IDT, Inc. (Coralville, IA) or Invitrogen.
The mouse TATA box binding protein (TBP) (Tamura et al., 1991) or
cyclophilin A genes were used as internal controls, because the mRNAs of
these genes are expressed in most tissues in approximately equal
amounts. Sequences for primers and probes are as follows: TBP primers:
5-CCCCTTGTACCCTTCACCAAT (forward) and 5- GAAGCTGCG-
GTACAATTCCAG (reverse); TBP fluorogenic probe: 5-TCCTGCCA-
CACCAGCTTCTGAGA; Cyclophilin A primers: 5-GCATACAGG-
TCCTGGCATCTT (forward) and 5-CATTCAGTCTTGGCAGTGCAG
(reverse); Cyclophilin A fluorogenic probe: 5-TGGAGCGTTTT-
GGGTCCAGGA;ICERprimers:5-GGTGACATGCCAACTTACCAGA-
(forward) and 5-TTGCGACTTGCTTCTTCTGC (reverse); ICER flu-
orogenic probe: 5-TGATGGCTGCCTCACCAGGAA; CRF primers:
5-CCGGGCAGAGCAGTTAGC (forward) and 5-CAACATTTCATT-
TCCCGATAATCTC (reverse); CRF fluorogenic probe: 5-CAGCAAG-
CTCACAGCAACAGGAAACTGAT.
The TBP and cyclophilin A probes were labeled at the 5 end with the
reporter fluorophore, Cy3, the ICER probe was labeled at the 5 end with
the reporter fluorophore Cy5, and the CRF probe was labeled at the 5
end with the reporter fluorophore, FAM. All probes were labeled at the 3
end with dark quenchers (BH-2 for ICER, TBP and cyclophilin A, and
BH-1 for CRF). To prevent probe extension, phosphate groups were
attached to the 3 ends of all probes. Multiplex PCR conditions were
optimized and used as follows: one cycle of 95°C for 10 min, followed by
40 cycles of 95°C for 30 sec and 60°C for 1 min. Amplicons were synthe-
sized and quantified using a Stratagene (La Jolla, CA) MX4000 thermo-
cycler system. Each sample was analyzed in triplicate using 1 TaqMan
Universal PCR Master Mix (Applied Biosystems) using 300 nM of each
TBP primer, 100 nM fluorogenic TBP probe, 300 nM CRF forward primer,
900 nM CRF reverse primer, and 250 nM fluorogenic CRF probe or using
300 nM of each cyclophilin A primer, 250 nM fluorogenic cyclophilin A
probe, 300 nM ICER forward primer, 900 nM ICER reverse primer, and
250 nM fluorogenic ICER probe in each replicate. Data were analyzed
using the comparative Ct method, as described in Applied Biosystems
User Bulletin Number 2 (P/N 4303859) and detailed by Livak and
Schmittgen (2001). For each replicate, an amplification plot was gener-
ated displaying the increase in the reporter dye fluorescence with each
cycle of PCR. From these data, Ct, defined as the fractional cycle number
at which the fluorescence passes a fixed threshold (based on the baseline
data collected in the first 15 cycles), was calculated. Therefore, for exam-
ple, for each sample an average Ct for CRF (CtCRF) and TBP (CtTBP) was
obtained. Samples were normalized against TBP using the following
equation:
CtTBP-CRFmean(CtTBP)mean(CtCRF).
CtTBP-CRF was calculated for each experimental group and differences
between groups were calculated using the following equation as an
example:
CtCRFwild-typesaline(CtTBP-CRF)wild-typeDMI(CtTBP-CRF),
where CtCRF represents the difference in CRF expression between
experimental groups compared. The magnitude of difference in CRF
gene expression is equal to 2 CtCRF . Relative CRF expression levels
were normalized to TBP and plotted relative to expression in saline-
treated wild-type mice, which equals 1. ICER expression was normalized
to cyclophilin A expression and plotted in the same manner.
Plasma corticosterone assays. On days 1 and 21, tail blood was collected
from each animal 20 min after FST test session (n  6 –12 per group),
separated into plasma by centrifugation and stored at 20°C until as-
sayed. Plasma corticosterone was measured by radioimmunoassay using
a commercially available kit (ICN Biomedicals Inc., Cleveland, OH).
Intra-assay coefficient of variation was 20% (average coefficient of
variation of 4.71%).
CRF immunohistochemistry. Mice were injected intracranially with 2
l of colchicine (20 mg/ml) and transcardially perfused 48 hr later with
25 ml of 0.1 M PBS followed by 60 ml of cold 4% paraformaldehyde. The
brains were removed and postfixed for 24 hr at 4°C, then placed in 30%
sucrose in 0.1 M PBS for at least 48 hr. Frozen-thin sections (10m) were
cut on a cryostat and mounted on glass slides (Fisher Plus Probe-on;
Fisher Scientific). Sections were processed to visualize CRF immunore-
activity as previously described (Valentino et al., 1992). Briefly, sections
were incubated in rabbit anti-CRF antiserum (PBL rC70, preabsorbed
with 2 mg human a globulins and 1 mg a-MSH per ml serum, provided
by Dr. Wylie Vale, The Salk Institute, San Diego, CA) at a 1:8000 dilution
in 0.1 M PBS containing 0.3% Triton X-100 and 0.04% bovine serum
albumin (PBST-BSA) and 0.1% sodium azide for 48 hr at 4°C. The spec-
ificity of this antisera has been previously described (Valentino et al.,
1992; Van Bockstaele et al., 1996). The primary antibody was applied
directly to the slide containing the sections, and another slide was used to
cover the reaction. Sections were rinsed in PBST-BSA (3 10 min) and
incubated in biotinylated donkey anti-rabbit antiserum (1:200 in PBST-
BSA) for 90 min at room temperature. The sections were then rinsed in
PBS and incubated in avidin– biotin complex (ABC Elite kit; Vector Lab-
oratories, Burlingame, CA). They were then rinsed in PBS (3 10 min)
and immersed in 0.02% 3,3-diaminobenzidine-4HCl (DAB; Sigma)
containing 0.01% H2O2 in PB for 10 –15 min at room temperature. All
solutions were made using diethylpyrocarbonate-treated reagents.
Paraventricular nucleus microdissection and aRNA amplification. After
CRF immunohistochemistry, stained tissue sections were photographed
and then treated with 200 l of 500 g/ml proteinase K for 30 min at
42°C. The localized region of CRF-expressing neurons of the paraven-
tricular nucleus (PVN) was microdissected under bright-field visualiza-
tion with a Zeiss (Frankfurt, Germany) Axiovert 25 microscope using an
Eppendorf MicroDissector equipped with an Eppendorf MicroChisel
that was positioned using a joystick micromanipulator. The microdis-
sected tissue was aspirated by pipette and transferred to a microfuge tube.
Sections were photographed after microdissection. Microdissected tissue
from four wild-type mice was concentrated to a volume of 10 l. RNA
amplification was carried out using the MessageAmp aRNA Kit (Am-
bion, Austin, TX) according to manufacturer’s instruction. cDNA from
the amplified RNA was synthesized as described previously.
Statistical analysis. All behavioral data were analyzed with a repeated
measures ANOVA with Newman–Keuls test used for post hoc compari-
sons of individual means. A Student’s t test was used to compare ICER
RT-PCR and real-time quantitative PCR data results between saline and
DMI-treated wild-type mice. For CRF real-time quantitative PCR data,
average differences in cycle thresholds were analyzed using a two-factor
ANOVA, with Fisher’s post hoc test used for comparisons of individual
means. Plasma corticosterone data were also analyzed using a two-factor
ANOVA and Fisher’s post hoc test for comparison of individual means.
Comparisons were considered statistically significant when p values were
0.05.
Results
DMI administration increases ICER expression
Mice were treated subchronically or chronically with DMI to
determine the effect of duration of antidepressant treatment on
ICER expression in various regions of the brain. After subchronic
DMI treatment, ICER expression was significantly upregulated in
hypothalamic, but not frontal cortical or hippocampal regions of
wild-type mice (Fig. 1) as determined by real-time quantitative
PCR. Amplification plots demonstrate that the cycle threshold
for ICER mRNA amplification in the hypothalamus is lower in
DMI-treated wild-type mice, indicating that hypothalamic ICER
expression is significantly upregulated after subchronic DMI ad-
ministration compared with saline controls (Fig. 1a). When nor-
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malized to cyclophilin A expression, DMI-treated wild-type mice
demonstrate an approximate twofold increase in ICER mRNA
compared with saline controls (Fig. 1b). To examine the effects of
chronic antidepressant administration on ICER expression, hy-
pothalamic, frontal cortical, and hippocampal tissue from wild-
type animals were evaluated after 21 d of DMI or saline treatment
using RT-PCR. After chronic administration of DMI, wild-type
mice continued to exhibit significantly increased levels of ICER
mRNA in the hypothalamus (Fig. 2). In contrast to subchronic
DMI treatment, chronic DMI administration significantly ele-
vated ICER mRNA levels in the frontal cortex (Fig. 2b). However,
chronic DMI administration did not alter ICER expression in the
hippocampus (Fig. 2b).
DMI administration reduces immobility in the FST and TST
in wild-type and ICER-deficient mice
To test the role of ICER in DMI-mediated behavioral alterations
in the FST, we administered saline and DMI (three doses over 24
hr: 10, 10, and 20 mg/kg, s.c.) to wild-type and ICER-deficient
mice and measured immobility. Subchronic administration of
DMI reduced immobility times in wild-type and mutant mice to
similar levels compared with respective saline controls (Fig. 3).
There is no quantifiable difference in basal locomotion of mutant
mice compared with wild-type mice when tested in home cage
activity monitors (data not shown). To examine the effects of
chronic DMI treatment on FST immobility, animals were main-
tained on twice daily injections of DMI or saline (10 mg/kg, i.p.)
for 21 d and re-evaluated in the FST on day 21 (Fig. 3). With
Figure 1. Real-time quantitative PCR analysis of ICER gene expression after subchronic an-
tidepressant treatment. a, Steady-state levels of hypothalamic ICER and cyclophilin A (as inter-
nal control) mRNAs were determined by real-time quantitative PCR after three injections of
saline or DMI in wild-type mice. Ten micrograms of total RNAs were reverse-transcribed into
cDNA and amplified using primer pairs and fluorogenic probes specific to ICER and cyclophilin A,
as described in Materials and Methods. Representative amplification plots of hypothalamic
cDNA expression are shown for saline- and DMI-treated wild-type mice. Data is presented as
fluorescence versus cycle number. Cycle threshold value is inversely proportional to the levels of
endogenous gene expression. DMI administration significantly increased hypothalamic, but not
frontal cortical or hippocampal ICER mRNA when compared with saline control (represented by
an decreased cycle threshold number). No significant differences in cycle thresholds for cyclo-
philin A mRNA were observed between groups. Cycle thresholds for both ICER and cyclophilin A
signals were 23–25 cycles, indicating similar levels of expression for these mRNAs within the
tissues examined. b, Cycle thresholds normalized to cyclophilin A determined in a were used to
calculate ICER mRNA levels in hypothalamus, frontal cortex, and hippocampus and plotted
relative to saline-treated wild-type mice (equal to 1). Subchronic DMI administration increased
ICER mRNA levels by approximately twofold in wild-type mice compared with saline controls in
the hypothalamus, but not in the frontal cortex or hippocampus. Student’s t test revealed the
following difference: *p 0.05 compared with corresponding saline control.
Figure 2. Reverse transcriptase PCR analysis of ICER gene expression after chronic antide-
pressant treatment. a, Steady-state levels of ICER and HPRT (as internal control) mRNAs in the
hypothalamus of wild-type mice were determined by RT-PCR after 21 d of saline or DMI admin-
istration. Ten micrograms of total RNAs were reverse transcribed into cDNA and amplified using
primer pairs specific to ICER and HPRT, as described in Materials and Methods. Three represen-
tative lanes are shown for saline and DMI treatment groups. ICER primers were designed to
amplify both ICER-1 and splice variant ICER-1, -RT, RNA-treated without reverse transcriptase
enzyme as control. b, Signals for total ICER mRNA (ICER-1 ICER-1) were quantified using a
PhosphorImager and normalized to that of HPRT and plotted. DMI administration significantly
increased ICER mRNA in the hypothalamus, frontal cortex, but not hippocampus of wild-type
mice compared with saline controls. Student’s t test revealed the following difference: *p
0.05 compared with saline control.
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chronic DMI administration, both wild-type and ICER-deficient
mice maintained significantly reduced immobility times over the
course of the study compared with respective saline controls.
Although the FST is generally an effective screen for measur-
ing the behavioral effects antidepressant drugs, it is not reliable
for testing selective serotonin reuptake inhibitors in mice with
this genetic background (Lucki, 2001). Therefore, mice were ex-
amined using the selective serotonin reuptake inhibitor fluox-
etine in the tail suspension test to rule out effects specific to
tricyclic antidepressants. Responses were compared with those of
DMI in the same testing session. Similar to the FST, acute and
chronic antidepressant treatment reduced immobility times in
wild-type and ICER-deficient mice in the TST compared with
respective saline controls (Fig. 4). Together these data demon-
strate that behavioral effects do not habituate throughout the
course of a chronic drug treatment in ICER-deficient mice and
that ICER is not required for the manifestation of behavioral
responses after acute or chronic DMI or fluoxetine
administration.
ICER is required for DMI-mediated suppression of
corticosterone release after FST
Unlike the TST, the FST is a potent activator of the HPA axis
(Connor et al., 2000). Therefore, to examine the stress-induced
endocrine response in ICER-deficient animals, blood samples
were taken 20 min and 1 hr after FST exposure for plasma corti-
costerone analysis after subchronic (Fig. 5a) and chronic (Fig. 5b)
DMI treatment. Corticosterone was significantly elevated in both
wild-type and ICER-deficient animals at 20 min after forced
swimming compared with non-swim stress controls (Fig. 5).
Corticosterone concentrations returned to control levels by 1 hr
after swim stress in both groups (data not shown). These data
demonstrate that ICER is not essential for the stress-induced en-
docrine response after swim exposure. Both subchronic (Fig. 5a)
and chronic (Fig. 5b) DMI administration significantly attenu-
ated swim stress-induced elevations in plasma corticosterone in
wild-type mice compared with saline-treated stress controls.
However, neither subchronic nor chronic DMI treatment was
able to suppress increased corticosterone concentrations in
ICER-deficient mice after FST exposure (Fig. 5).
ICER is required for DMI mediated downregulation of CRF
mRNA in the hypothalamus
CRF regulates corticosterone release and may also mediate the
effects of DMI on HPA axis activity. Therefore, to elucidate the
molecular mechanism by which DMI suppresses corticosterone
release acutely after swim stress, mice were examined for alter-
ations in hypothalamic CRF expression using real-time quantita-
tive PCR. Amplification plots demonstrate that the cycle thresh-
old for CRF mRNA amplification is greater in DMI-treated wild-
type mice, indicating that CRF expression is significantly
downregulated in wild-type mice treated chronically with DMI
after FST exposure compared with saline controls (Fig. 6a).
When normalized to TBP expression, DMI-treated wild-type
mice demonstrate an approximate twofold reduction in CRF
mRNA compared with wild-type saline controls (Fig. 6b). How-
ever, this DMI-induced downregulation of CRF expression did
not occur in ICER mutant mice. CRF mRNA levels in DMI-
treated ICER-deficient mice were equivalent to saline-treated
wild-type and mutant mice exposed to swim stress (Fig. 6b).
These data suggest that ICER is critical to the mechanism by
which DMI reduces CRF mRNA. To verify the presence of ICER
within the region of CRF-expressing neurons in the PVN (Fig.
7a), these neurons were microdissected from wild-type mice (Fig.
7b) and examined for ICER expression using real-time quantita-
tive PCR (Fig. 7c). The results provide evidence for concurrent
expression of CRF, ICER, and cyclophilin A in cells of the PVN.
Together, these data indicate that ICER, acting as a potent CRF
Figure 3. Behavioral response of wild-type and ICER-deficient mice in the forced swim test
after antidepressant treatment. Animals were administered saline or DMI twice daily (10 mg/
kg, i.p.) with 20 mg/kg subcutaneously administered on testing days and evaluated for immo-
bility in the FST. DMI treatment significantly reduced immobility times in both wild-type and
ICER-deficient mice on day 1 (subchronic) and 21 (chronic) of the treatment paradigm com-
pared with respective saline controls. Results are presented as mean immobility SEM (in
seconds). Repeated measures ANOVA and post hoc Newman–Keuls pairwise comparisons re-
vealed the following differences: *p 0.05 compared with corresponding saline control.
Figure 4. Behavioral response of wild-type and ICER-deficient mice in the tail suspension
test after antidepressant treatment. Animals were administered saline, DMI, or FLX (20 mg/kg,
i.p.) 30 min before a 6 min test session and evaluated for immobility in the TST. Between testing
days, animals were maintained on twice daily saline or DMI (10 mg/kg, i.p.) injections. Acute
(day 1) and chronic (day 21) FLX and DMI significantly reduced immobility times in both wild-
type and ICER-deficient mice compared with respective saline controls. Results are presented as
mean immobility  SEM (sec). ANOVA and post hoc Newman–Keuls pairwise comparisons
revealed the following differences: *p 0.05 compared with corresponding saline control.
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repressor, is critical to the mechanism by which DMI regulates
corticosterone secretion after swim stress.
Discussion
The cAMP–protein kinase A pathway has been identified as an
important signaling system involved in the effects of stress and
repeated antidepressant drug administration. Within this path-
way the transcription factor CREB has been well studied (Nibuya
et al., 1996; Conti et al., 2002), however the impact of a highly
related protein, CREM, is not well described. The CREM gene
encodes a variety of isoforms through alternative splicing that
function as either activators or repressors of cAMP-responsive
transcription (Foulkes et al., 1991, 1992; Delmas et al., 1992;
Foulkes and Sassone-Corsi, 1992; Laoide et al., 1993). Deletion of
the CREM gene in the mouse results in the loss of all of these
isoforms and causes male mice to be sterile (Blendy et al., 1996;
Nantel et al., 1996). This phenotype most likely results from de-
letion of the CREM activator isoform CREM , which is highly
expressed in testes (Foulkes et al., 1992). The functional conse-
quences resulting from deletion of repressor isoforms, such as
ICER, however, have not been examined in these mice. In con-
trast to CREM  activity, ICER is suggested to regulate compo-
Figure 5. Plasma corticosterone concentration after exposure to the forced swim test. Ani-
mals were examined for changes in the stress hormone corticosterone with and without FST
exposure. In wild-type and ICER mutant mice, swim stress induced a significant elevation in
corticosterone levels compared with respective non-swim stressed control mice 20 min after
swim exposure on day 1 ( a) and day 21 ( b). Administration of subchronic ( a) and chronic ( b)
DMI significantly blunted the elevation in corticosterone in wild-type mice compared with
saline-treated swim-stressed controls. In ICER mutant mice, however, neither subchronic ( a)
nor chronic ( b) DMI administration was able to suppress swim stress-induced elevations in
corticosterone. Values are presented as mean corticosterone SEM (in micrograms per deca-
liter). Results are presented as mean immobility SEM (in seconds). ANOVA and Fisher’s post
hoc test for comparison of individual means revealed the following differences: *p  0.05
compared with corresponding non-swim stress control and **p 0.05 compared with corre-
sponding swim stress saline control.
Figure 6. Real-time quantitative PCR analysis of CRF gene expression after exposure to swim
stress. a, Steady-state levels of hypothalamic CRF and TBP (as internal control) mRNAs were
determined by real-time quantitative PCR after 21 d of saline or DMI administration in wild-type
or ICER-deficient mice. Ten micrograms of total RNAs were reverse-transcribed into cDNA and
amplified using primer pairs and fluorogenic probes specific to CRF and TBP as described in
Materials and Methods. Representative amplification plots are shown for saline and DMI treat-
ment groups for wild-type and ICER-deficient mice. Data is presented as fluorescence versus
cycle number. Cycle threshold value is inversely proportional to the levels of endogenous gene
expression. DMI administration significantly reduced CRF mRNA after swim stress compared
with wild-type saline control (represented by an increased cycle threshold number). DMI was
unable to blunt CRF mRNA expression in ICER-deficient mice compared with saline controls. No
significant differences in TBP mRNA were observed between groups. Cycle thresholds for both
CRF and TBP signals were 23–25 cycles, indicating similar levels of expression for these mRNAs
within the tissues examined. b, Cycle thresholds normalized to TBP determined in a were used
to calculate the CRF mRNA levels and plotted relative to saline-treated wild-type mice (equal to
1). DMI reduced CRF mRNA levels by approximately twofold in wild-type mice compared with
wild-type saline controls. ANOVA and post hoc Fisher’s pairwise comparisons revealed the fol-
lowing differences: *p 0.05 compared with corresponding saline control andp 0.05
compared with DMI-treated ICER-deficient mice.
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nents of the HPA axis and limbic system (Fitzgerald et al., 1996a;
Della Fazia et al., 1998; Mazzucchelli and Sassone-Corsi, 1999).
The ICER protein consists primarily of a basic–leucine zipper
region, which allows heterodimerization with all CREM and
CREB proteins, resulting in nonactivating dimers (Stehle et al.,
1993). The presence of four tandem CRE sequences in the ICER
promoter suggests cAMP inducibility, therefore ICER is classified
as an early response gene (Molina et al., 1993).
Previous studies have suggested a role for regulation of early
response genes, like c-fos, c-jun, and ICER, by antidepressant
treatments. Acute DMI administration (Dahmen et al., 1997) as
well as electroconvulsive seizure (ECS) (Cole et al., 1990) have
been shown to induce immediate early gene expression in the rat
brain, however, to date only ECS has been shown to significantly
upregulate ICER expression in the rat frontal cortex and hip-
pocampus. ICER is also sensitive to adrenergic stimulation,
which is a characteristic of most tricyclic antidepressants. In line
with this evidence, we demonstrate here that ICER expression is
significantly increased after chronic DMI treatment in mouse
frontal cortex, but not hippocampus. Furthermore, after both
subchronic and chronic DMI treatment, ICER expression is in-
creased in the hypothalamus. Preliminary studies indicate that
chronic fluoxetine (10 mg/kg) does not alter levels of ICER in
either frontal cortex or hippocampus (data not shown), however
regulation in the hypothalamus has not been examined. These
data indicate that ICER may be a critical molecular mediator of
tricyclic antidepressant function.
One approach to identify genes that may contribute to a psy-
chiatric illness, such as depression, involves the genetic dissection
of complex phenotypes into endophenotypes, measurable bio-
logical traits that are associated with target disease phenotypes.
Clinically, depression involves alterations in behavioral as well as
endocrine responses, however the functional relationship that
exists between these two responses is not well defined. Therefore,
in our animal model, we examined both the behavioral responses
associated with antidepressant administration as well as the en-
docrine alterations associated with desipramine treatment to
evaluate if ICER is a molecular mediator of one or both of these
outcome measures.
Behavioral models, such as the FST and TST, are widely used
for preclinical assessment of antidepressant activity (Cryan et al.,
2002). We evaluated ICER-deficient mice in both paradigms to
determine if ICER is involved in mediating DMI-induced behav-
iors. ICER-deficient mice respond to DMI similarly to wild-type
mice in the FST and TST, indicating that ICER is not required for
the expression of the behavioral responses to antidepressant drug
treatment. These data parallel previous studies from our labora-
tory demonstrating that CREB deficiency does not compromise
behavioral responses to antidepressant drugs (Conti et al., 2002).
However, in contrast to CREB-deficient mice, which demon-
strate a baseline change in immobility behavior, ICER-deficient
mice have similar levels of immobility as wild-type controls in
both the FST and TST. Furthermore, similar to wild-type con-
trols, ICER-deficient mice exhibited a significant reduction in
immobility after both DMI and FLX in the tail suspension test,
indicating a general responsivity of ICER-deficient mice to at
least two classes of antidepressant drugs.
Psychiatric morbidity associated with depression can often be
accompanied or even precipitated by stress. There is close clinical
and biochemical resemblance between depressive symptoms and
the response to stressful experiences, which led to the hypothesis
that depression represents activation of the primary mediators of
the stress response. As a result, dysregulation of the HPA axis has
been implicated in depression and its treatment. Clinical data
indicates that a subset of patients with depression exhibit hyper-
activity of the HPA axis, which is normalized after successful
antidepressant therapy (Asnis et al., 1992; Holsboer-Trachsler et
al., 1994; Gold et al., 1995; Heuser et al., 1996; Arborelius et al.,
1999; Sapolsky, 2000).
Previous reports suggest that ICER induction is coupled to the
HPA axis in response to stress (Della Fazia et al., 1998; Mazzuc-
chelli and Sassone-Corsi, 1999). Stress associated with the FST
activates the HPA axis and causes significant elevations of corti-
costerone (Connor et al., 2000). However, in the present study we
demonstrate that both wild-type and ICER-deficient mice exhibit
Figure 7. Colocalization of ICER and CRF mRNA in PVN neurons of the hypothalamus. a,
CRF-expressing PVN neurons in wild-type mice were identified using immunohistochemical
techniques as described in Materials and Methods. b, CRF-expressing cells in the PVN were
microdissected and processed for aRNA amplification and cDNA synthesis. c, CRF-expressing
cells were examined for ICER coexpression using real-time quantitative PCR. aRNA from CRF-
positive PVN cells was reverse transcribed into cDNA and amplified using primer pairs and
fluorogenic probes specific to CRF, ICER, and cyclophilin A (as internal control), as described in
Materials and Methods. Representative amplification plots are shown. Data is presented as
fluorescence versus cycle number.
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similar elevations in serum corticosterone concentration after
swim stress compared with respective non-stress controls, indi-
cating that ICER is not critical for the corticosterone response to
swim stress. This finding parallels previous studies that report
normal responses of CREM mutant mice to behavioral stress
(Maldonado et al., 1999).
Furthermore, our data demonstrate that swim stress-induced
elevation in corticosterone concentration is attenuated by DMI
administration in wild-type mice. These data are in agreement
with previous studies in the rat that document the attenuation of
swim stress associated elevation in serum corticosterone by DMI
(Connor et al., 2000; Conti et al., 2002), but not by selective
serotonin reuptake inhibitors (Connor et al., 2000). In contrast,
swim stress-induced elevation in corticosterone is not blocked by
DMI administration in ICER-deficient mice, indicating that
ICER is critical to the mechanism by which DMI mediates HPA
axis activity. In addition, these findings also indicate that the
molecular mechanisms that activate stress responses after the
FST, which are unaffected in ICER-deficient mice, are distinct
from those used by DMI to suppress these responses.
DMI treatment is suggested to reduce serum corticosterone
concentrations by a variety of mechanisms, including suppres-
sion of CRF expression (Brady et al., 1991; Centeno and Volosin,
1997). Using real-time quantitative PCR we demonstrate that
chronic DMI treatment significantly decreases CRF mRNA ex-
pression in the hypothalamus of wild-type mice after swim stress.
Chronic DMI treatment also significantly increases hypotha-
lamic ICER mRNA expression. In contrast, ICER-deficient mice
fail to demonstrate reductions in swim stress-induced CRF ex-
pression after DMI treatment. Together these data suggest that
ICER negatively regulates hypothalamic CRF mRNA expression.
In further support of these findings, we demonstrate that ICER is
enriched in CRF-expressing cells of the PVN, suggesting the po-
tential for a direct interaction between this transcription factor
and its target gene. Indeed, the presence of a CRE element in the
promoter region of the CRF gene indicates that regulation may
occur via a CRE-binding mechanism (Meyer et al., 1993). Recent
studies in two hypothalamic cell lines demonstrate that co-
transfection of ICER with a luciferase reporter gene driven by a
CRF promoter fragment markedly inhibited basal and forskolin-
stimulated CRF promoter activity (Kalitchenko et al., 2003; Liu et
al., 2003). Together, these data reveal a novel role for ICER as a
strong transcriptional repressor of CRF, and that ICER expres-
sion may result in downregulation of CRF mRNA and subse-
quently, attenuated corticosterone secretion.
Response to antidepressant treatment can be observed at the
behavioral and endocrine levels. The relationship between the
underlying mechanisms associated with these responses and the
impact they have on clinical outcome is complex and may con-
tribute to the variability in efficacy often observed with antide-
pressant treatment. We have used a combination of approaches
to examine the role of CRE transcription factors in mediating the
behavioral and endocrine consequences of antidepressant treat-
ment. Previously, we have shown that an activator of CRE-
mediated gene expression, CREB, is not required for behavioral
responses to antidepressant drugs (Conti et al., 2002). In a similar
manner, we now demonstrate that a strong repressor of CRE-
mediated gene expression, ICER, is dispensable for behavioral
responses. In contrast, although CREB deficiency does not affect
the endocrine response to antidepressant treatment, an ICER
deficiency clearly compromises this response. Hence, antidepres-
sant modulation of the HPA axis may depend more on repression
(ICER) of CRE-mediated gene expression than on activation
(CREB). Whether or not HPA axis abnormalities are a primary
cause of depression, stress is clearly an important causative factor
in the development or expression of depressive symptoms. For
this reason, new developments in antidepressant medications
have focused on CRF receptor antagonists (Arborelius et al.,
1999; O’Brien et al., 2001). In a similar manner, identification of
the molecules associated with downregulation of the CRF gene,
such as ICER, may identify new targets for novel antidepressant
drugs.
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